Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05761301
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2023-02-24
Brief Title:
A Phase 12 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM
Sponsor:
Alnylam Pharmaceuticals
Organization:
Alnylam Pharmaceuticals